MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 12.02.2026
AVITA Medical EV 2011-2026 | RCEL
EV Jährlich AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 166 M | 290 M | 483 M | 219 M | 197 M | 368 M | 360 M | 50 M | 52.9 M | 43.3 M | 27 M | 40.8 M | 47.5 M | 54.5 M | 1.54 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 483 M | 1.54 M | 160 M |
EV anderer Aktien in der Medizinische Geräte
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
15.2 B | $ 186.55 | 3.25 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
1.55 B | $ 34.35 | 2.63 % | $ 1.58 B | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 12.74 | 3.41 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
10.1 B | $ 292.85 | 1.72 % | $ 8.26 B | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.23 | -2.86 % | $ 121 M |  France |
 |
Bruker Corporation
BRKR
|
3.81 B | $ 40.2 | 2.93 % | $ 5.99 K | USA |
 |
Boston Scientific Corporation
BSX
|
111 B | $ 64.08 | 1.43 % | $ 94.9 B | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 10.4 | 3.92 % | $ 294 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.03 | 0.1 % | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
170 M | $ 25.3 | 1.83 % | $ 214 M | USA |
 |
Inogen
INGN
|
163 M | $ 6.42 | -0.54 % | $ 171 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
142 M | $ 6.07 | 2.45 % | $ 72.6 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
12.7 B | $ 95.6 | 2.82 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 1.99 | -1.97 % | $ 1.21 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 4.43 | 3.62 % | $ 938 M | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 17.74 | 4.63 % | $ 416 M | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 10.79 | 3.25 % | $ 387 M | USA |
 |
Myomo
MYO
|
47 M | $ 0.77 | 4.83 % | $ 32.2 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 56.09 | 2.2 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 39.43 | 2.52 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 65.33 | 1.16 % | $ 3.56 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 88.62 | 1.01 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
91.5 M | $ 18.76 | 0.27 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 77.69 | -0.56 % | $ 45.4 B | USA |